Bridgeway Capital Management LLC Trims Holdings in Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Bridgeway Capital Management LLC trimmed its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 89.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,476 shares of the business services provider's stock after selling 304,756 shares during the period. Bridgeway Capital Management LLC owned about 0.11% of Cross Country Healthcare worth $662,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Quadrant Capital Group LLC purchased a new stake in shares of Cross Country Healthcare in the 4th quarter valued at approximately $25,000. Plato Investment Management Ltd purchased a new stake in shares of Cross Country Healthcare in the 4th quarter valued at approximately $46,000. Mint Tower Capital Management B.V. purchased a new stake in shares of Cross Country Healthcare in the 4th quarter valued at approximately $182,000. Guggenheim Capital LLC purchased a new stake in shares of Cross Country Healthcare in the 4th quarter valued at approximately $201,000. Finally, Envestnet Asset Management Inc. purchased a new stake in shares of Cross Country Healthcare in the 4th quarter valued at approximately $217,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Cross Country Healthcare Trading Up 0.9%

Shares of NASDAQ:CCRN opened at $14.03 on Monday. Cross Country Healthcare, Inc. has a 52 week low of $9.58 and a 52 week high of $18.50. The company's 50 day moving average is $14.61 and its two-hundred day moving average is $15.45. The company has a market cap of $459.95 million, a PE ratio of -280.54, a P/E/G ratio of 3.32 and a beta of 0.38.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. During the same period in the prior year, the firm posted $0.19 EPS. The business's revenue was down 22.6% on a year-over-year basis. As a group, equities research analysts expect that Cross Country Healthcare, Inc. will post 0.53 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently weighed in on CCRN. Barrington Research reaffirmed a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a research note on Friday, March 14th. JMP Securities reaffirmed a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Finally, StockNews.com began coverage on shares of Cross Country Healthcare in a research note on Wednesday, May 7th. They set a "hold" rating on the stock. Six research analysts have rated the stock with a hold rating, According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $18.41.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Want to see what other hedge funds are holding CCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.